| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Avenacy, LLC | 20260109 | 1 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Gland Pharma Limited | 20260108 | 4 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB FOR INJECTION, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Ningbo Shuangcheng Pharmaceutical Co., Ltd. | Hainan Shuangcheng Pharmaceuticals Co., Ltd. | 20251230 | 3 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Eugia US LLC | EUGIA Pharma Specialities Limited | 20251223 | 1 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | BluePoint Laboratories | Kindos Pharmaceuticals Co., LTD | 20251120 | 5 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Apotex Corp | Apotex Inc | 20250916 | 6 |
| These highlights do not include all the information needed to use VELCADE safely and effectively. See full prescribing information for VELCADE. VELCADE ® (bortezomib) for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Takeda Pharmaceuticals America, Inc. | 20250828 | 36 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | BluePoint Laboratories | MSN LABORATORIES PRIVATE LIMITED | 20250731 | 2 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Meitheal Pharmaceuticals Inc. | Kindos Pharmaceuticals Co., LTD | 20250723 | 6 |
| These highlights do not include all the information needed to use BORUZU safely and effectively. See full prescribing information for BORUZU. BORUZU ® (bortezomib injection), for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Amneal Pharmaceuticals LLC | Amneal Oncology Private Limited | 20250705 | 2 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Somerset Therapeutics LLC | Reliance Life Sciences Private Limited | 20250510 | 1 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION . BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | NorthStar RxLLC | Dr.Reddy's Laboratories Limited (FTO-7) | Dr. Reddy's Laboratories Limited (FTO-11) | 20250506 | 3 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Sagent Pharmaceuticals | 20250505 | 1 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Fresenius Kabi USA, LLC | 20250327 | 7 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Zydus Pharmaceuticals USA Inc. | Zydus Hospira Oncology Private Limited | 20241205 | 3 |
| These highlights do not include all the information needed to use BORTEZOMIB INJECTION safely and effectively. See full prescribing information for BORTEZOMIB INJECTION. BORTEZOMIB injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Shilpa Medicare Limited | Amneal Oncology Private Limited | 20240830 | 1 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Camber Pharmaceuticals, Inc. | Hetero Labs Limited Unit VI | 20240722 | 1 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION . BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Dr.Reddy's Laboratories, Inc. | Dr.Reddy's Laboratories Limited (FTO-7) | Dr.Reddy's Laboratories Limited (FTO-11) | 20240517 | 17 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Hospira, Inc. | 20240409 | 2 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 20231121 | 2 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Eugia US LLC | EUGIA Pharma Specialities Limited | 20231020 | 3 |
| These highlights do not include all the information needed to useBORTEZOMIB FOR INJECTIONsafely and effectively. See full prescribing information forBORTEZOMIB FOR INJECTION. BORTEZOMIBfor injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Sintetica US LLC | MSN Laboratories Private Limited | 20231009 | 2 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Hospira, Inc. | Gland Pharma Limited | 20230227 | 3 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Novadoz Pharmaceuticals LLC | MSN LABORATORIES PRIVATE LIMITED | 20220720 | 1 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | BluePoint Laboratories | Qilu Pharmaceutical (Hainan) Co., Ltd. | 20220516 | 1 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Qilu Pharmaceutical Co., Ltd. | Qilu Pharmaceutical (Hainan) Co., Ltd. | 20220509 | 1 |
| BORTEZOMIB for injection, for subcutaneous or intravenous use | Zydus Lifesciences Limited | Zydus Hospira Oncology Private Limited | 20220505 | 1 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Pharmascience Inc. | 20220502 | 8 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB FOR INJECTION (bortezomib) for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Waverley Pharma Inc | Reliance Life Sciences Pvt Ltd | 20220413 | 3 |
| These highlights do not include all the information needed to use BORTEZOMIB FOR INJECTION safely and effectively. See full prescribing information for BORTEZOMIB FOR INJECTION. BORTEZOMIB for injection, for subcutaneous or intravenous use Initial U.S. Approval: 2003 | Hikma Pharmaceuticals USA Inc. | Jiangsu Hansoh Pharmaceutical Group Co., Ltd. | 20211122 | 2 |
| These highlights do not include all the information needed to use BORTEZOMIB INJECTION safely and effectively.See full prescribing information for BORTEZOMIB INJECTION. BORTEZOMIB injection, for intravenous use Initial U.S. Approval: 2003 | MAIA Pharmaceuticals, Inc. | Gland Pharma Limited | 20210922 | 1 |